LGC Standards strengthens its position in Asia with first China office

17-Apr-2009 - China

LGC Standards has opened its first office in Beijing, China. The new office will enable the company to bring its range of laboratory products and services to the Chinese market.

LGC Standards provides a range of products and services for measurement and laboratory control encompassing reference material distribution and proficiency testing, together with the production of pharmaceutical impurities and custom synthesis. For the first time the company will be able to support Chinese laboratories directly by offering logistical and technical advice in their local language.

The new office will be managed by Dr Chen Hong, who has over 10 years’ experience in major international companies. Dr Chen Hong obtained her degrees in analytical chemistry and biochemistry fields, and her PhD was obtained from the University of Tokyo in Japan. Mr Frank Lai also joins the company as a pharmaceutical specialist, with a bachelor’s degree from Shenyang pharmaceutical University, China and over seven years’ experience in pharmaceutical laboratories and industry.

Dr Matthias Brommer, Director, LGC Standards said: “The opening of our first Chinese office clearly demonstrates that LGC Standards is committed to providing global quality management solutions for laboratories worldwide. Our Chinese team will focus on supplying laboratories in the pharmaceutical, environmental, food, industrial and forensic sectors with reference materials and proficiency testing schemes to support laboratory quality.”

Other news from the department business & finance

These products might interest you

Systec H-Series

Systec H-Series by Systec

Safe, reproducible and validatable sterilization of liquids, solids and waste

Autoclaves with 65-1580 liters usable space, flexibly expandable for various applications

laboratory autoclaves
Whatman™ folded filter papers

Whatman™ folded filter papers by Cytiva

Whatman folded filter papers

Convenient folded formats speed up your sample preparation

filter papers
Loading...

Most read news

More news from our other portals

Is artificial intelligence revolutionizing the life sciences?

Last viewed contents

DSM Announces Biologics Development and Manufacturing Agreement for Australian Facility

Analytica China 2014: Closed with overall success - analytica China further strengthens its position as leading platform

More sensitive MRI diagnostics thanks to innovative “elastic” contrast media

More sensitive MRI diagnostics thanks to innovative “elastic” contrast media

Threading the Molecular Needle: ASU Biodesign Researcher to Explore Revolutionary Gene Sequencing - National Institutes of Health awarded a $550,000 three-year grant

Society for Clinical Data Management (SCDM) - Brüssel, Belgium

Society for Clinical Data Management (SCDM) - Brüssel, Belgium

New gene transfer strategy shows promise for limb girdle and other muscular dystrophies

Computer simulation of protein malfunction related to Alzheimer's disease

AI tailors artificial DNA for future drug development - DNA molecules made-to-order: “What otherwise takes years is now shortened to weeks or days”

AI tailors artificial DNA for future drug development - DNA molecules made-to-order: “What otherwise takes years is now shortened to weeks or days”

Merck Expands Corporate Venture Fund M Ventures with a New Investment of € 600 Million - “Over the past decade, M Ventures has established itself globally as a leading partner to the biotech and tech venture ecosystems”

Merck Expands Corporate Venture Fund M Ventures with a New Investment of € 600 Million - “Over the past decade, M Ventures has established itself globally as a leading partner to the biotech and tech venture ecosystems”

Bacterial soundtracks revealed by graphene membrane - Have you ever wondered if bacteria make distinctive sounds?

Bacterial soundtracks revealed by graphene membrane - Have you ever wondered if bacteria make distinctive sounds?

BioNTech to Raise USD 250 Million in Private Placement - The private placement includes an investment in ordinary shares and a investment in 4-year mandatory convertible notes

BioNTech to Raise USD 250 Million in Private Placement - The private placement includes an investment in ordinary shares and a investment in 4-year mandatory convertible notes

Eurofins opens new faciltiy in Livingston